Fresenius increases credit facility to $4.4 billion, extends maturity

By Marisa Wong

Madison, Wis., Dec. 1 – Fresenius Medical Care AG & Co. KGaA announced it upsized its syndicated credit facility by the equivalent of $850 million to a total equivalent of about $4.4 billion, with pricing and other conditions more favorable to the company.

The amended credit facility consists of revolving facilities and term loans, both dollar- and euro-denominated.

The final maturity date was extended by two years to Oct. 30, 2019.

The facilities will be used to refinance existing debt, for working capital needs and for general corporate purposes.

Fresenius said it also successfully extended its $800 million accounts receivable facility with improved terms. The new facility will now mature Nov. 24, 2017.

Fresenius is a Bad Homburg-based provider of dialysis products and services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.